Researcher
Yven Van Herrewege
Affiliations
- Institute of Tropical Medicine (Research institute)
Member
From17 Jan 2000 → 31 Oct 2007 - Clinical Trials Unit (Research unit)
Member
From17 Jan 2000 → Today
Projects
1 - 2 of 2 results
Publications
1 - 10 of 16 results
- Time of administration of rabies immunoglobulins and adequacy of antibody response upon post-exposure prophylaxis: a descriptive retrospective study in Belgium(2019)
Authors: Patrick Soentjens, Mieke Croughs, Christophe Burm, Steven Declerq, Joannes Clerinx, Ula Maniewski-Kelner, Steven Van Den Broucke, Caroline Theunissen, Ralph Huits, Isabel Brosius, et al.
Pages: 1-7Number of pages: 7 - Comparative immunogenicity and safety trial of 2 different schedules of single-visit intradermal rabies postexposure vaccination(2019)
Authors: Patrick Soentjens, Katrien De Koninck, Achilleas Tsoumanis, Natacha Herssens, Dorien Van Den Bossche, Sanne Terryn, Steven Van Gucht, Pierre Van Damme, Yven Van Herrewege, Emmanuel Bottieau
Pages: 797-804Number of pages: 8 - Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days(2019)
Authors: Patrick Soentjens, P Andries, A Aerssens, Achilleas Tsoumanis, Raffaella Ravinetto, W Heuninckx, Harry van Loen, B Brochier, S Van Gucht, P Van Damme, et al.
Pages: 607-614Number of pages: 8 - In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20)(2009)
Authors: MA Jenabian, H Saïdi, C Charpentier, Yven Van Herrewege, JC Son, D Schols, J Balzarini, G Vanham, L Bélec
Pages: 1192-1195Number of pages: 4 - CD4 mimetic miniproteins(2008)
Authors: Yven Van Herrewege, L Morellato, A Descours, LAETITIA AERTS, Johan Michiels, Leo Heyndrickx, L Martin, G Vanham
Pages: 818-826Number of pages: 9 - CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor(2008)
Authors: K Vermeire, J Brouwers, Yven Van Herrewege, R Le Grand, G Vanham, P Augustijns, TW Bell, D Schols
Pages: 246-256Number of pages: 11 - Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays(2008)
Authors: Leo Heyndrickx, Tine Vermoesen, Katleen Vereecken, J Kurth, Sandra Coppens, LAETITIA AERTS, A Ohagen, Yven Van Herrewege, P Lewi, G Vanham
Pages: 166-173Number of pages: 8 - Human immunodeficiency virus type 1 (HIV-1) integration(2008)
Authors: Yven Van Herrewege, D Hazuda, P Lewi, R Costi, R Di Santo, A Cara, G Vanham
Pages: 2544-2554Number of pages: 11 - A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides(2007)
Authors: Yven Van Herrewege, Johan Michiels, A Waeytens, G De Boeck, EVELYNE SALDEN, Leo Heyndrickx, G van den Mooter, MP de Béthune, K Andries, P Lewi, et al.
Pages: 111-124 - In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection(2007)
Authors: K Terrazas-Aranda, Yven Van Herrewege, PJ Lewi, J Van Roey, G Vanham
Pages: 141-151